We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+5.66%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$80.1B
AUM Growth
+$9.71B
(+14%)
Cap. Flow
+$17.3B
Cap. Flow
% of AUM
21.56%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
1,430
New
62
Increased
858
Reduced
440
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$13B |
| 2 |
NVIDIA
NVDA
|
+$468M |
| 3 |
ASML
ASML
|
+$424M |
| 4 |
Applied Materials
AMAT
|
+$310M |
| 5 |
Qualcomm
QCOM
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinross Gold
KGC
|
+$444M |
| 2 |
Tyler Technologies
TYL
|
+$256M |
| 3 |
C.H. Robinson
CHRW
|
+$251M |
| 4 |
Philip Morris
PM
|
+$245M |
| 5 |
RTX Corp
RTX
|
+$234M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.76% |
| 2 | Materials | 26.89% |
| 3 | Healthcare | 7.04% |
| 4 | Industrials | 6.5% |
| 5 | Financials | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
KeyCorp
KEY
$24.5B
| $137K | ﹤0.01% |
8,029
+457
| +6% | +$7.25K |
|
1227
CEVA Inc
CEVA
$927M
| $135K | ﹤0.01% |
5,645
+88
| +2% | +$1.91K |
|
1228
Perion Network
PERI
$382M
| $134K | ﹤0.01% |
16,801
+261
| +2% | +$2.19K |
|
1229
ATS Corp
ATS
$2.69B
| $132K | ﹤0.01% |
4,230
+936
| +28% | +$27.1K |
|
1230
Integer Holdings
ITGR
$4.23B
| $132K | ﹤0.01% |
1,047
-239
| -19% | -$29.2K |
|
1231
Synaptics
SYNA
$4.13B
| $132K | ﹤0.01% |
+1,848
| New | +$148K |
|
1232
Envista
NVST
$4.45B
| $131K | ﹤0.01% |
6,872
-924
| -12% | -$16.1K |
|
1233
Equitable Holdings
EQH
$13.1B
| $129K | ﹤0.01% |
2,834
+161
| +6% | +$6.61K |
|
1234
Nano X Imaging
NNOX
$76.6M
| $128K | ﹤0.01% |
22,644
+351
| +2% | +$2.49K |
|
1235
Smith & Nephew
SNN
$13.5B
| $128K | ﹤0.01% |
4,375
-3,199
| -42% | -$94.9K |
|
1236
Vinci Compass Investments Ltd
VINP
$650M
| $127K | ﹤0.01% |
12,717
+1,208
| +10% | +$12.9K |
|
|
AHRT
1237
AH Realty Trust
AHRT
$527M
| $126K | ﹤0.01% |
11,403
+1,251
| +12% | +$14.6K |
|
1238
Semtech
SMTC
$11.1B
| $125K | ﹤0.01% |
+2,801
| New | +$103K |
|
|
HPP
1239
Hudson Pacific Properties
HPP
$786M
| $123K | ﹤0.01% |
3,817
+343
| +10% | +$12.3K |
|
1240
Ovintiv
OVV
$17.1B
| $123K | ﹤0.01% |
3,114
+178
| +6% | +$7.7K |
|
1241
SiTime
SITM
$16.5B
| $123K | ﹤0.01% |
+682
| New | +$97.6K |
|
1242
Tandem Diabetes Care
TNDM
$1.38B
| $123K | ﹤0.01% |
3,827
-324
| -8% | -$13.7K |
|
1243
Onto Innovation
ONTO
$13.4B
| $118K | ﹤0.01% |
586
+130
| +29% | +$26.2K |
|
1244
Transmedics
TMDX
$2.82B
| $117K | ﹤0.01% |
987
-192
| -16% | -$29.6K |
|
1245
Afya
AFYA
$1.3B
| $115K | ﹤0.01% |
6,821
-1,410
| -17% | -$24.4K |
|
|
INN
1246
Summit Hotel Properties
INN
$749M
| $111K | ﹤0.01% |
18,037
+1,980
| +12% | +$12.6K |
|
1247
Delek Logistics
DKL
$3.09B
| $108K | ﹤0.01% |
2,780
-549
| -16% | -$22.4K |
|
1248
RxSight
RXST
$260M
| $108K | ﹤0.01% |
2,225
-158
| -7% | -$8.1K |
|
1249
STAAR Surgical
STAA
$1.21B
| $105K | ﹤0.01% |
3,478
+393
| +13% | +$14.7K |
|
|
SVC
1250
Service Properties Trust
SVC
$1.02B
| $102K | ﹤0.01% |
5,670
+622
| +12% | +$15.5K |
|
Similar funds
VanEck Associates's Q3 2024 Portfolio in Review
As of Q3 2024, VanEck Associates held 1,430 positions worth $80.1B, up 14% from $70.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
VanEck Associates deployed $17.3B of net new capital in Q3 2024, opening 62 new positions and adding to 858 existing holdings. Its largest new stake was GE HealthCare: 2,335,235 shares worth $209M.
By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Materials and Healthcare.
On the sell side, the largest reduction was Kinross Gold, an estimated $444M trimmed.
- VanEck Associates's largest Q3 2024 buy was GE HealthCare: 2,335,235 shares worth $209M.
- VanEck Associates added most to Lam Research in Q3 2024, an estimated $13B increase.
- VanEck Associates's biggest Q3 2024 reduction was Kinross Gold, cutting an estimated $444M.
- VanEck Associates fully exited RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock in Q3 2024, selling an estimated $22.4M.
- VanEck Associates's ten largest holdings make up 29% of its $80.1B portfolio in Q3 2024.
- VanEck Associates opened 62 new positions and closed 53 in Q3 2024.
- VanEck Associates's portfolio value rose 14% quarter-over-quarter to $80.1B.
Based on VanEck Associates's 13F filing for Q3 2024, filed 29 Oct 2024.